Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
DEPT OF DEFENSE has floated a tender for Antidote Treatment Nerve Agent Auto-Injector (Atnaa). The project location is USA and the tender is closing on 04 Apr 2024. The tender notice number is SPE2DP-23-R-0002, while the TOT Ref Number is 99090676. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : USA
Summary : Antidote Treatment Nerve Agent Auto-Injector (Atnaa)
Deadline : 04 Apr 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 99090676
Document Ref. No. : SPE2DP-23-R-0002
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
Solicitation: SPE2DP-23-R-0002
Item: ANTIDOTE TREATMENT, NERVE AGENT, Automatic, Dual-Chamber, Pralidoxime Chloride Injection, 300 mg per mL, 2 mL, and Atropine Injection, 2.99 mg per mL, 0.7 mL
NSN: 6505-01-362-7427
Description:
The Defense Logistics Agency Troop Support has a requirement for the supply of Antidote Treatment Nerve Agent Auto-Injector (ATNAA). ATNAA shall be made in accordance with MPID Number 6 dated May 2, 2019.
The Solicitation will be issued under authority 10 U.S.C. 2304(c)(1).
The Government does not intend to use Part 12 for this acquisition - per FAR 10.002(d)(2).
The proposed contract will be a firm-fixed price, indefinite delivery, indefinite quantity type contract. The contract will consist of a base year and four (4) one-year options. The quantities for the base year and each option year are a minimum of 225, 000 each and a maximum of 1, 000, 000 each.
Inspection/Acceptance at Origin
FOB Destination
Delivery Destination: Susquehanna, PA
Production Lead Time is 164 days after issuance date of the delivery order (DD1155).
All responsible sources may submit a proposal and shall be considered by the Agency.
The successful contractor shall have FDA approval to sell ATNAA before award decision.
****************************************************************************
IMPORTANT NOTICES
Availability of solicitations, FAR 5.102(d) applies, as our office no longer issues solicitations or amendments in paper form. Offeror should register to receive notification of this solicitation or solicitation amendments. The solicitation will be posted on the DLA Internet Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil/. Detailed system requirements and instructions for registration can be found on the DLA DIBBS Home Page accessed on https://www.dibbs.bsm.dla.mil/. Once the solicitation is posted, it will be available for viewing on DIBBS. From the DIBBS homepage, s...
Active Contract Opportunity Notice ID SPE2DP-23-R-0002 Related Notice Department/Ind. Agency DEPT OF DEFENSE Sub-tier DEFENSE LOGISTICS AGENCY Major Command TROOP SUPPORT MEDICAL Office DLA TROOP SUPPORT
General Information
Contract Opportunity Type: Presolicitation (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Mar 20, 2024 07:52 am EDT
Original Response Date: Apr 04, 2024 11:59 pm EDT
Inactive Policy: 15 days after response date
Original Inactive Date: Apr 19, 2024
Initiative: None
Classification
Original Set Aside:
Product Service Code: 6505 - DRUGS AND BIOLOGICALS
NAICS Code: 325414 - Biological Product (except Diagnostic) Manufacturing
Place of Performance: Philadelphia, PA 19111 USA
Documents
Want To Bid in This Tender?
Get Local Agent Support in USA and 60 More Countries.
View Tenders By
Sign in with Google